Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their potential use in drugs, raises $300M Series B – a Boston-based company that will bring drugs to market has raised $110 million in the series, working to improve the way B Funding from Koch Disruptive Technologies.
